Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Does MOTS-c Help Metabolism Research: Research Model Comparison

MOTS-c demonstrates distinct metabolic effects across research models. The following comparison outlines primary outcomes, mechanisms, and research applications based on published preclinical studies. Diet-Induced Obesity (DIO) Prevention of insulin resistance

This comparison does not assign a generated winner or score.

  • MOTS-c demonstrates distinct metabolic effects across research models. The following comparison outlines primary outcomes, mechanisms, and research applications based on published preclinical studies.
  • Diet-Induced Obesity (DIO)
  • Prevention of insulin resistance despite HFD; 30–40% reduction in weight gain vs controls
  • AMPK activation → increased fatty acid oxidation; reduced lipid intermediate accumulation in muscle
  • 5–15 mg/kg IP injection, 3×/week
  • 4–8 weeks for glucose tolerance improvement; 8–12 weeks for body composition change
  • Metabolic disease prevention models; insulin resistance mechanism studies
  • Aged Mice (18–24 months)
  • Restoration of glucose tolerance to young-mouse levels; 40–55% reduction in fasting insulin
  • Mitochondrial biogenesis; improved oxidative capacity in skeletal muscle; FOXO3a activation
  • 4–6 weeks for insulin sensitivity; 6–8 weeks for mitochondrial density increase
  • Age-related metabolic decline; sarcopenia models; healthspan extension research
  • Exercise Endurance Models
  • 20–35% increase in time-to-exhaustion; improved substrate utilization (fat oxidation, glycogen sparing)
  • Enhanced mitochondrial efficiency; upregulation of PGC-1α and oxidative enzymes
  • 5–10 mg/kg IP 2–4 hours pre-exercise
  • Acute (within single session); chronic adaptations at 3–4 weeks
  • Exercise physiology; metabolic flexibility; performance enhancement pathways
  • Oxidative Stress Challenge
  • 60–70% reduction in cell death from paraquat or H₂O₂ exposure; maintained ATP production under stress
  • Upregulation of SOD2, catalase, GPx1 via AMPK/FOXO3a; preservation of mitochondrial membrane potential
  • 10–50 μM in vitro; 5–15 mg/kg in vivo
  • 12–24 hours for antioxidant enzyme upregulation
  • Mitochondrial stress resistance; neuroprotection models; oxidative damage pathways
  • Heat Stress Models
  • Maintained thermoregulation; 50% lower post-stress lactate; faster metabolic recovery
  • Preservation of oxidative metabolism under heat shock; reduced glycolytic shift
  • 10 mg/kg IP administered 2–4 hours pre-stress
  • Immediate (acute stress response)
  • Environmental stress adaptation; metabolic resilience under physiological challenge
  • The table demonstrates that does MOTS-c help metabolism research extends across multiple disease models and mechanistic pathways. The consistent AMPK activation and mitochondrial function improvement make it a versatile tool for investigators studying metabolic disease, aging, and stress adaptation.
More references

Related material